Why is Sandu Pharma. falling/rising?

As of 18-Nov, Sandu Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 41.78, which represents a decrease of Rs. 1.05 or 2.45%. The stock has hit a new 52-week low of Rs. 38 today, reflecting a significant drop of 11.28% at its intraday low. Over the past week, the stock has underperformed its sector by 1.89% and has seen a consecutive fall over the last two days, accumulating a total decline of 3.98%. Additionally, the stock is trading below its moving averages across various time frames, indicating a bearish trend. There has also been a notable decrease in investor participation, with delivery volume dropping by 71.14% compared to the five-day average, which further suggests weakening investor interest.
In the broader market context, Sandu Pharmaceuticals has underperformed significantly compared to the Sensex, with a year-to-date return of -27.03% against the benchmark's gain of 8.36%. Over the past month, the stock has declined by 5.35%, while the Sensex has increased by 0.86%. This stark contrast highlights the stock's struggles relative to the overall market performance. The high volatility observed today, with an intraday volatility of 6.75%, coupled with a wide trading range of Rs. 5.5, indicates uncertainty among investors regarding the stock's future direction. Overall, the combination of negative performance metrics and declining investor engagement contributes to the downward pressure on Sandu Pharmaceuticals' stock price.